Amylyx to release Phase 3 avexitide trial results Aug. 18

August 17, 2026 4:01 PM

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) is set to release topline results from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found